UB Paderborn / Katalog / Suche / in CDI

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study

Endocrine-related cancer, 2019-02, Vol.26 (2), p.227-239

2019

Volltextzugriff (PDF)

Lung Carcinoids: A Comprehensive Review for Clinicians

Cancers, 2023-11, Vol.15 (22), p.5440

2023

Volltextzugriff (PDF)

Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity

Neuroendocrinology, 2016-01, Vol.103 (3-4), p.345-353

2016

Volltextzugriff (PDF)

Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors

Clinical cancer research, 2007-05, Vol.13 (10), p.2986-2991

2007

Volltextzugriff (PDF)

Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours

PloS one, 2014-01, Vol.9 (1), p.e86756-e86756

2014

Volltextzugriff (PDF)

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors

Cancer, 2001-09, Vol.92 (5), p.1101-1107

2001

Volltextzugriff (PDF)

630 EO2401, a new peptide immunotherapy against cancer, in combination with nivolumab, induces a strong and durable immune response in patients from the EOADR1–19/SPENCER study

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A719-A719

2023

Volltextzugriff (PDF)

Metastatic Pheochromocytomas and Abdominal Paragangliomas

The journal of clinical endocrinology and metabolism, 2021-05, Vol.106 (5), p.e1937-e1952

2021

Volltextzugriff (PDF)

Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors

Upsala journal of medical sciences, 2017-01, Vol.122 (1), p.43-50

2017

Volltextzugriff (PDF)

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE

Cancers, 2019-06, Vol.11 (7), p.909

2019

Volltextzugriff (PDF)

A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N

Frontiers in pediatrics, 2022, Vol.10, p.836230

2022

Volltextzugriff (PDF)

The Cytotoxic Agents NSC-95397, Brefeldin A, Bortezomib and Sanguinarine Induce Apoptosis in Neuroendocrine Tumors In Vitro

Anticancer research, 2010-01, Vol.30 (1), p.149-156

2010

Volltextzugriff (PDF)

Bronchial carcinoids

International journal of endocrine oncology, 2019-03, Vol.6 (1)

Granberg, Dan

2019

Volltextzugriff (PDF)

Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification

The Journal of nuclear medicine (1978), 2014-02, Vol.55 (2), p.204-210

2014

Volltextzugriff (PDF)

Gastric carcinoid in a patient infected with Helicobacter pylori： A new entity

World journal of gastroenterology : WJG, 2011-07, Vol.17 (25), p.3066-3068

2011

Volltextzugriff (PDF)

Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US Experience

International Journal of Hepatology, 2011-01, Vol.2011, p.742890-7

2011

Volltextzugriff (PDF)

Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment

The Journal of nuclear medicine (1978), 2013, Vol.54 (1), p.33-41

2013

Volltextzugriff (PDF)

Treatment of Liver Metastases in Patients with Neuroendocrine Tumors: A Comprehensive Review

International Journal of Hepatology, 2011-01, Vol.2011, p.154541-11

2011

Volltextzugriff (PDF)

Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Advanced Lung Neuroendocrine Tumors

Chest, 2013-04, Vol.143 (4), p.955-962

2013

Volltextzugriff (PDF)

The cytotoxic effect of emetine and CGP-74514A studied with the hollow fiber model and ArrayScan assay in neuroendocrine tumors in vitro

Anti-cancer agents in medicinal chemistry, 2012-09, Vol.12 (7), p.783

2012

Volltextzugriff (PDF)

Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated with Chemotherapy: Analysis of Outcome, Safety, and Their Determinants

Neuroendocrinology, 2021-03, Vol.111 (4), p.330

2021

Volltextzugriff (PDF)

Identification and Evaluation of Potential Anti-cancer Drugs on Human Neuroendocrine Tumor Cell Lines

Anticancer research, 2006-11, Vol.26 (6B), p.4125-4129

2006

Volltextzugriff (PDF)

Comparative Biodistribution and Radiation Dosimetry of Ga-68-DOTATOC and Ga-68-DOTATATE in Patients with Neuroendocrine Tumors

The Journal of nuclear medicine (1978), 2013-10, Vol.54 (10), p.1755

2013

Volltextzugriff (PDF)

Selective Internal Radiation Therapy for Gastrointestinal Neuroendocrine Tumour Liver Metastases: A New and Effective Modality for Treatment

International Journal of Hepatology, 2011-01, Vol.2011, p.404916-7

2011

Volltextzugriff (PDF)

Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study

Chest, 2013-04, Vol.143 (4), p.955-962

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study

Lung Carcinoids: A Comprehensive Review for Clinicians

Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity

Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors

Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors

630 EO2401, a new peptide immunotherapy against cancer, in combination with nivolumab, induces a strong and durable immune response in patients from the EOADR1–19/SPENCER study

Metastatic Pheochromocytomas and Abdominal Paragangliomas

Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE

A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N

The Cytotoxic Agents NSC-95397, Brefeldin A, Bortezomib and Sanguinarine Induce Apoptosis in Neuroendocrine Tumors In Vitro

Bronchial carcinoids

Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification

Gastric carcinoid in a patient infected with Helicobacter pylori： A new entity

Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US Experience

Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment

Treatment of Liver Metastases in Patients with Neuroendocrine Tumors: A Comprehensive Review

Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Advanced Lung Neuroendocrine Tumors

The cytotoxic effect of emetine and CGP-74514A studied with the hollow fiber model and ArrayScan assay in neuroendocrine tumors in vitro

Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated with Chemotherapy: Analysis of Outcome, Safety, and Their Determinants

Identification and Evaluation of Potential Anti-cancer Drugs on Human Neuroendocrine Tumor Cell Lines

Comparative Biodistribution and Radiation Dosimetry of Ga-68-DOTATOC and Ga-68-DOTATATE in Patients with Neuroendocrine Tumors

Selective Internal Radiation Therapy for Gastrointestinal Neuroendocrine Tumour Liver Metastases: A New and Effective Modality for Treatment

Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study

Suchergebnisse filtern